Table III.
Characteristics | AKI (n = 22) | Non-AKI (n = 117) | P value |
---|---|---|---|
| |||
Age | 69.47 (6.65) | 71.44 (8.79) | 0.2354 |
Male | 13 (59.1) | 77 (65.8) | 0.5449 |
Congestive Heart Failure | 4 (18.2) | 31 (26.5) | 0.5932 |
Hypertension | 19 (86.4) | 104 (88.9) | 0.7193 |
Smoking | 22 (100.0) | 101 (86.3) | 0.0752 |
COPD | 10 (45.5) | 56 (47.9) | 1.0000 |
Diabetes | 4 (18.2) | 22 (18.8) | 1.0000 |
History of Stroke | 4 (18.2) | 33 (28.2) | 0.4346 |
Baseline eGFR | 65.50 [58.25, 81.50] | 63.00 [52.00, 85.00] | 0.6348 |
Baseline Creatinine | 0.92 [0.82, 1.24] | 1.06 [0.83, 1.24] | 0.5199 |
Baseline CKD Stage 3/4/5 | 3 (13.6) | 21 (17.9) | 0.7658 |
Symptomatic | 8 (36.4) | 36 (30.8) | 0.6229 |
Active or Contained Rupture | 1 (4.5) | 4 (3.4) | 0.5833 |
Aortic Angulation | |||
Thoracic | 48.45 [22.50, 73.38] | 30.00 [15.00, 52.10] | 0.0654 |
Diaphragm | 42.70 [25.75, 100.00] | 30.00 [20.00, 36.67] | 0.0227 |
Renal | 31.35 [16.25, 77.50] | 20.90 [11.00, 38.83] | 0.0951 |
Hemoglobin < 7 | 4 (18.2) | 8 (6.8) | 0.0984 |
ASA Score III/IV/V | 22 (100.0) | 117 (100.0) | NA |
Contrast Volume (mL) | 78.00 [54.75, 173.50] | 91.00 [57.00, 140.00] | 0.9563 |
Intervention Time (min) | 398.50 [275.25, 511.00] | 254.00 [197.00, 375.00] | 0.0023 |
Fluoroscopy Time (min) | 117.00 [87.30, 157.30] | 77.10 [65.40, 108.70] | 0.0041 |
Accessory renal sacrifice | 1 (6.7) | 8 (8.2) | 1.0000 |
Aneurysm type | 0.2655 | ||
Crawford I-III Aneurysm | 13 (59.1) | 43 (36.8) | |
Crawford IV Aneurysm | 6 (27.3) | 33 (28.2) | |
Crawford V Aneurysm | 0 (0.0) | 2 (1.7) | |
Para/juxtarenal Aneurysm | 3 (13.6) | 28 (23.9) | |
Retrograde Type B Aortic Dissection | 0 (0.0) | 11 (9.4) |
CKD, Chronic Kidney Disease; COPD, Chronic Obstructive Pulmonary Disease.
Categorical variables are presented as number (%). Continuous variables are presented as mean (standard deviation) or median [interquartile range].